Clinical Trials in Michigan

Showing 681-700 of 7,755 trials

Observational Study of LUMRYZ in Narcolepsy

NCT06792708

This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.

Narcolepsy

Avadel71 participantsStarted Jul 2024

Bradenton, Florida, United States • East Lansing, Michigan, United States • Middletown, New Jersey, United States +9 more locations

RECRUITINGPHASE341 miles

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

NCT07104383

This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight

Weight Loss

Viking Therapeutics, Inc.1,100 participantsStarted Jun 2025

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +131 more locations

Observational Study of LUMRYZ in Narcolepsy

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Find Trials by Condition in Michigan

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

Eliminating Monitor Overuse Trial (EMO Trial)

Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

REFLECT Scoliosis System Post Approval Study

AQT90 FLEX NTproBNP2 Test Kit Matrix Comparison and Sample Stability Verification Study

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)